Penggunaan Dexmedetomidin pada Neurotrauma

MM Rudi Prihatno, Abdul Lian, Nazaruddin Umar

Abstract


Penggunaan dexmedetomidin dalam neurotrauma masih terpecah antara yang setuju dan tidak setuju. Permasalahan ketidaksetujuan adalah dari sisi penilaian terhadap kesadaran pasien, sedangkan yang menyetujui pemberian dexmedetomidin lebih cenderung digunakan sebagai sedasi dan juga efeknya sebagai protektor otak. Permasalahan tersebut diatas dapat dijadikan pertimbangan oleh ahli anestesi dalam penatalaksanaan neurotrauma dengan tetap mempertimbangkan kondisi fisik dan kesadaran pasien dengan harapan agar keselamatan pasien tetap terjaga dengan baik dan tidak memperburuk kondisi pasien.

 

The Use of Dexmedetomidine on Neurotrauma

The use of dexmedetomidine in Neurotrauma still divided between the agree and disagree. Disagreement is the issue of the assessment of patient awareness, while approving the provision of dexmedetomidine were more likely to be used as a sedative and also its effect as a brain protector. The problems mentioned above can be considered by an anesthesiologist in the management of Neurotrauma while considering the physical condition and consciousness of the patient with the expectation that patient safety is maintained properly and not worsen the patient's condition.


Keywords


Dexmedetomidin; neurotauma; proteksi otak dexmedetomidine; neurotrauma; brain protection

Full Text:

PDF

References


Bekker A, Sturaitis MK. Dexmedetomidine for neurological surgery. J Neurosurgery. 2005[diunduh 10 April 2010];57 Suppl 1:1-10. Tersedia dari: http://anesthesia.ucsf.edu/neuroanesthesia/residents/respdf/Dexmedetomidin_neurosurgery.pdf

Nelson LE, Lu J, Guo T, Sappor CB, Franks NP, Maze M. The α2-adrenoceptor agonist dexmedetomidine convergeson an endogenous sleep-promoting pathway to exert its sedative effects. Anesthesiology.2003;98:428 –36.

Kumar GK. Dexmedetomidin [dokumen di internet]. Madras Medical College[diunduh 20 Februari 2010]. Tersedia dari:http://www.isakanyakumari.com/docs/Dexmedetomidin%20text.pdf

Okawa K, Ichinohe T, Kaneko Y. A comparison of propofol and dexmedetomidine for intravenous sedation: a randomized, crossover study of the effects on the central and autonomic nervous systems. J Anesth Analg. 2010;110(2):415-8.

Poree RL, Guo TZ, Kingery WS, Maze M. The analgesic potency of dexmedetomidine is enhanced after nerve injury: A possible role for peripheral α2-adrenoceptors. Anesth Analg. 1998;87:941-8.

McCallum JB, Boban N, Hogan Q, Schmelling WT, Kampine JP, Bosnjak ZJ. The mechanism of α2-adrenergic inhibition of sympathetic ganglionic transmission. Anesth Analg.1998;87:503-10.

Talke P, Chen R, Thomas B, Aggarwall A, Gottlieb A, Thorborg P, et al. The hemodynamic and adrenergic effects of perioperative dexmedetomidine infusion after vascular surgery. Anesth Analg. 2000; 90(4):834-9.

Arcangeli A, Alo CD, Gaspari R. Dexmedetomidine use in general anesthesia. Current Drug Targets. 2009;10:687-95.

Aanta R, Jaakola ML, Kallio A, Kanto J. Eduction of the MAC of isoflurane by dexmedetomidine. J Anesth. 1997;86:1055-60

Weinger MB, Segal IS, Maze M. Dexmedetomidine, acting through central α-2 adrenoceptors, prevent opiate-induced muscle rigidity in the rat. J Anesth. 1989; 71:242-49.

Caldwell JE, Talke PO, Richardson CA, Nielsen HK, Stafford M. The effects of dexmedetomidine on neuromuscular blockade in human volunteers. Anesth Analg 1999;88:633–9.

Repici M, Mariani J, Borsello T. Neuronal death and neuroprotection: a review. Dalam: Borsello T, ed. Neuroprotection methods and protocol. New Jersey: Humana Press; 2007, 1-14.

Marmarou A. The pathophysiology of brain edema and elevated intracranial pressure. Clev Clin J Med. 2004(71) Suppl 1:6-8.

Janke EL, Samra S. Dexmedetomidine and neuroprotection. J Sem in Anesth, Periop Med and Pain. 2006;25:71-6.

Tobias JD. Dexmedetomidine in trauma anesthesiology and critical care. J Int Trauma Anesth and Crit Care. 2007[diunduh 21 November 2010](17)1:6-18. Tersedia dari :http://www.itaccs.com

Abramov D. The role of dexmedetomidine in the sedation of critically ill patients. J Pharm Therapeutics. 2005(30)3:158-61.

Lawrence CJ, Prinzen FW, Lange S. The effect of dexmedetomidine on nutrient organ blood flow. Anesth Analg. 1996;83:1160-5.

Venn RM, Bradshaw CJ, Spencer R, et al. Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit. Anaesthesia. 1999;54:1136-42.

Hall JE, Uhrich TD, Barney JA, et al. Sedative, amnestic, and analgesic properties of dexmedetomidine infusions. Anesth Analg. 2000;90:699-705.

Kamibayashi T, Maze M. Clinical uses of α2-adrenergic agonist. Anesthesiology. 2000; 93:1345–9




DOI: https://doi.org/10.24244/jni.vol1i3.173

Refbacks

  • There are currently no refbacks.


                                    

 

JNI is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License